12:00 AM
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cervarix regulatory update

GSK said it submitted a regulatory application to EMA for a 2-dose schedule of Cervarix to be administered at 0 and 6 months to prevent...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >